Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Neuronal Signaling>AChR antagonist>Tiotropium bromide hydrate
Tiotropium bromide hydrate
  • Tiotropium bromide hydrate

Tiotropium bromide hydrate

Price $10
Package 1G
Min. Order: 1G
Supply Ability: 1000KG
Update Time: 2023-09-15

Product Details

Product Name: Tiotropium bromide hydrate CAS No.: 139404-48-1
EC-No.: 690-508-4 Min. Order: 1G
Purity: 99.9% Supply Ability: 1000KG
Release date: 2023/09/15
  • Common Name: Tiotropium bromide hydrate

  • CAS: 139404-48-1

  • MF: C19H22BrNO4S2.H2O

  • MW: 490.43

  • EINECS: 690-508-4

  • Form: Powder/Crystal

  • Color: White/Yelllowish-white


Port: Shanghai, China


Production Capacity: 20t Per Month


Payment: L/C, T/T, D/P, Western Union, Paypal, Money Gram, BTC


Customized: Customized


Certification: GMP, HSE, ISO 9001, USP, BP


Package: Customized


Brand: LIHE



Related Products

Article illustration

Hot Selling Products


  • 79099-07-3   1-Boc-4-Piperidone

  • 40064-34-4    4-Piperidone Hydrochloride Monohydrate

  • 288573-56-8    1-BOC-4-(4-FLUORO-PHENYLAMINO)-PIPERIDINE

  • 1451-82-7          2-Bromo-4'-methylpropiophenone

  • 5413-05-8          Ethyl 2-phenylacetoacetate

  • 16595-80-5        Levamisole hydrochloride

  • 20320-59-6        Diethyl(phenylacetyl)malonate

  • 28578-16-7        2-Oxiranecarboxylicacid, 3-(1,3-benzodioxol-5-yl)-2-Methyl-, ethyl ester

  • 136-47-0            Tetracaine HCl

  • 102-97-6            N-Isopropylbenzylamine

  • 94-09-7              Benzocaine

  • 443998-65-0    1-BOC-4-(4-BROMO-PHENYLAMINO)-PIPERIDINE


Contact us

Wickr Me: sakurazhu
Whatsapp/ Telegram: +86 18186183733
Skype/E-mail: sakura@lihepharma.com
Wechat: 18186183733

Company Profile Introduction

Lihe Pharm(Wuhan) Technology Co., Ltd. is a company specializing in the production and management of pharmaceutical intermediates and chemical import and export trade. Our company has long-term cooperation with Wuhan Research Institute and various universities and has a complete scientific research system and quality certification. system. The company has two pilot production bases, which are mainly engaged in the production of APIs, pharmaceutical intermediates, and the customization of special chemicals. After several years of operation, the products are sold at home and abroad and won numerous praises. In the future operations, we will continue to adhere to the principles of cooperation, keeping promises, sincerity, equality, mutual benefit and mutual benefit, and provide you with high-quality services. We sincerely welcome friends from all walks of life at home and abroad to visit and guide and cooperate sincerely.

Article illustration


Company Profile Introduction

Lihe Pharmaceutical Technology (Wuhan) Co., Ltd. is a pharmaceutical company integrating product development, production and chemical intermediates, specializing in the research, development, production and export of organic intermediates, pharmaceutical intermediates, chemical solvents and pesticides

You may like

Recommended supplier

Product name Price   Suppliers Update time
$10.00/1kg
VIP1Y
Wuhan Xinhao Biotechnology Co., Ltd
2024-03-11
$0.00/1kg
VIP2Y
Hebei Kingfiner Technology Development Co.Ltd
2023-12-22
$10.00/1kg
Anhui Zhongda Biotechnology Co., Ltd
2023-10-30
$100.00/25kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-09-15
$0.00/25Kg/Bag
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2023-06-01
$20.00/1kg
Hebei Brisk New Material Technology Co. , Ltd.
2023-06-01
$200.00/10g
Hebei Best Biological Technology Co., Ltd
2022-11-03
$0.00/25KG
PNP Biotech Co. Ltd
2022-10-26
$5.00/1KG
XINGTAI XINGJIU NEW MATERIAL TECHNOLOGY CO., LTD
2022-01-13
$150.00/1g
Hebei Mingeng Biotechnology Co., Ltd
2021-12-07
  • Since: 2022-04-18
  • Address: C018, No. 5, Floor 0615, Building 06, Building 06, Engineering Design Headquarters, Unit 3, Optics V
INQUIRY